Heartburn in patients with gastro-oesophageal reflux disease in Germany and SwedenA study on patients’ burden of disease

被引：0
|
作者：
Roger Jones
Silke Horbach
Peter Sander
Tina Rydén-Bergsten
机构：
[1] King’s College London,
[2] ALTANA Pharma AG,undefined
[3] AstraZeneca,undefined
[4] R&D,undefined
来源：
PharmacoEconomics | 2003年 / 21卷
关键词：
Chronic Fatigue Syndrome; Reflux Symptom; Gastrointestinal Symptom Rate Scale; Swedish Patient; Respiratory System Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Gastro-oesophageal reflux disease (GORD) is widespread in the general population and presents in most cases with heartburn as the main symptom. The severity of symptoms is not necessarily related to erosive damage to the oesophagus due to acid reflux, but the frequency and severity of symptoms have an impact on the health-related QOL (HR-QOL) of the patient.
引用
收藏
页码：1091 / 1102
页数：11
相关论文
共 50 条
  • [1] Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden -: A study on patients burden of disease
    Jones, R
    Horbach, S
    Sander, P
    Rydén-Bergsten, T
    [J]. PHARMACOECONOMICS, 2003, 21 (15) : 1091 - 1102
  • [2] Heartburn, gastro-oesophageal reflux disease and nonerosive reflux disease
    Smith, Haley
    [J]. SA PHARMACEUTICAL JOURNAL, 2013, 80 (01) : 16 - 20
  • [3] Burden of illness in Italian patients with gastro-oesophageal reflux disease
    Pacini, F
    Calabrese, C
    Cipolletta, L
    Valva, MD
    Russo, A
    Savarino, V
    Vigneri, S
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (04) : 495 - 502
  • [4] Heartburn, gastro-oesophageal reflux disease and non-erosive reflux disease
    Smith, Haley
    [J]. SA PHARMACEUTICAL JOURNAL, 2016, 83 (04) : 9 - +
  • [5] Heartburn, gastro-oesophageal reflux disease and non-erosive reflux disease
    Smith, Haley
    [J]. SA PHARMACEUTICAL JOURNAL, 2019, 86 (01) : 41 - 45
  • [6] Gastro-oesophageal reflux disease in paediatric patients
    Terblanche, Alta
    [J]. SA PHARMACEUTICAL JOURNAL, 2011, 78 (07) : 24 - 26
  • [7] The global burden of gastro-oesophageal reflux disease: more than just heartburn and regurgitation
    Sweis, Rami
    Fox, Mark
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (06): : 519 - 521
  • [8] Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study
    Lembo, T
    Ippoliti, AF
    Ramers, C
    Weinstein, WM
    [J]. GUT, 1999, 45 (04) : 484 - 488
  • [9] Heartburn during sleep: a clinical marker of gastro-oesophageal reflux disease in morbidly obese patients
    Fornari, F.
    Madalosso, C. A. S.
    Callegari-Jacques, S. M.
    Gurski, R. R.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (02): : 136 - 142
  • [10] Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease
    Peura, D. A.
    Pilmer, B.
    Hunt, B.
    Mody, R.
    Perez, M. C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (10) : 1303 - 1311
12345